FGFR4 and metastatic neoplasm: Considering that the clinical behavior of tumors harboring specific genetic aberrations may be different between localized resectable and metastatic disease, our data on prognosis may have some limitations for indicating the impact of high FGFR4 expression in patients with metastatic iCCA.